Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1994 Sep 15;151(6):791–793.

At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol.

E M Yoshida 1, M A Karim 1, J F Shaikh 1, J G Soos 1, S R Erb 1
PMCID: PMC1337134  PMID: 8087755

Full text

PDF
791

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayres M. L., Jarrett P. E., Browse N. L. Blood viscosity, Raynaud's phenomenon and the effect of fibrinolytic enhancement. Br J Surg. 1981 Jan;68(1):51–54. doi: 10.1002/bjs.1800680117. [DOI] [PubMed] [Google Scholar]
  2. Burnand K., Clemenson G., Morland M., Jarrett P. E., Browse N. L. Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression. Br Med J. 1980 Jan 5;280(6206):7–11. doi: 10.1136/bmj.280.6206.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cowart V. S. Ethical, as well as physiological, questions continue to arise over athletes' steroid abuse. JAMA. 1989 Jun 16;261(23):3362-3, 3367. doi: 10.1001/jama.1989.03420230014005. [DOI] [PubMed] [Google Scholar]
  4. Cowart V. Steroids in sports: after four decades, time to return these genies to bottle? JAMA. 1987 Jan 23;257(4):421-3, 427. [PubMed] [Google Scholar]
  5. DAWSON J. L. POST-OPERATIVE RENAL FUNCTION IN OBSTRUCTIVE JAUNDICE: EFFECT OF A MANNITOL DIURESIS. Br Med J. 1965 Jan 9;1(5427):82–86. doi: 10.1136/bmj.1.5427.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DAWSON J. L. THE INCIDENCE OF POSTOPERATIVE RENAL FAILURE IN OBSTRUCTIVE JAUNDICE. Br J Surg. 1965 Sep;52:663–665. doi: 10.1002/bjs.1800520906. [DOI] [PubMed] [Google Scholar]
  7. Elashoff J. D., Jacknow A. D., Shain S. G., Braunstein G. D. Effects of anabolic-androgenic steroids on muscular strength. Ann Intern Med. 1991 Sep 1;115(5):387–393. doi: 10.7326/0003-4819-115-5-387. [DOI] [PubMed] [Google Scholar]
  8. Evely R. S., Triger D. R., Milnes J. P., Low-Beer T. S., Williams R. Severe cholestasis associated with stanozolol. Br Med J (Clin Res Ed) 1987 Mar 7;294(6572):612–613. doi: 10.1136/bmj.294.6572.612-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FOSS G. L., SIMPSON S. L. Oral methyltestosterone and jaundice. Br Med J. 1959 Jan 31;1(5117):259–263. doi: 10.1136/bmj.1.5117.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Falanga V., Kirsner R. S., Eaglstein W. H., Katz M. H., Kerdel F. A. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet. 1991 Aug 10;338(8763):347–348. doi: 10.1016/0140-6736(91)90483-6. [DOI] [PubMed] [Google Scholar]
  11. Ferner R. E., Rawlins M. D. Anabolic steroids: the power and the glory? BMJ. 1988 Oct 8;297(6653):877–878. doi: 10.1136/bmj.297.6653.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Green J., Beyar R., Bomzon L., Finberg J. P., Better O. S. Jaundice, the circulation and the kidney. Nephron. 1984;37(3):145–152. doi: 10.1159/000183235. [DOI] [PubMed] [Google Scholar]
  13. Ishak K. G., Zimmerman H. J. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis. 1987 Aug;7(3):230–236. doi: 10.1055/s-2008-1040579. [DOI] [PubMed] [Google Scholar]
  14. LaBree M. A review of anabolic steroids: uses and effects. J Sports Med Phys Fitness. 1991 Dec;31(4):618–626. [PubMed] [Google Scholar]
  15. Marshall E. The drug of champions. Science. 1988 Oct 14;242(4876):183–184. doi: 10.1126/science.3175643. [DOI] [PubMed] [Google Scholar]
  16. Oms L., Martínez-Ródenas F., Valverde J., Jiménez W., Sitges-Serra A. Reduced water and sodium intakes associated with high levels of natriuretic factor following common bile duct ligation in the rabbit. Br J Surg. 1990 Jul;77(7):752–755. doi: 10.1002/bjs.1800770712. [DOI] [PubMed] [Google Scholar]
  17. Tuchweber B., Weber A., Roy C. C., Yousef I. M. Mechanisms of experimentally induced intrahepatic cholestasis. Prog Liver Dis. 1986;8:161–178. [PubMed] [Google Scholar]
  18. Veneri R. J., Gordon S. C. Anabolic steroid-induced cholestasis: choleretic response to corticosteroids. J Clin Gastroenterol. 1988 Aug;10(4):467–468. [PubMed] [Google Scholar]
  19. Wait R. B., Kahng K. U. Renal failure complicating obstructive jaundice. Am J Surg. 1989 Feb;157(2):256–263. doi: 10.1016/0002-9610(89)90540-0. [DOI] [PubMed] [Google Scholar]
  20. Westaby D., Ogle S. J., Paradinas F. J., Randell J. B., Murray-Lyon I. M. Liver damage from long-term methyltestosterone. Lancet. 1977 Aug 6;2(8032):262–263. [PubMed] [Google Scholar]
  21. Wilson J. D. Androgen abuse by athletes. Endocr Rev. 1988 May;9(2):181–199. doi: 10.1210/edrv-9-2-181. [DOI] [PubMed] [Google Scholar]
  22. Windsor R., Dumitru D. Prevalence of anabolic steroid use by male and female adolescents. Med Sci Sports Exerc. 1989 Oct;21(5):494–497. [PubMed] [Google Scholar]
  23. Winwood P. J., Robertson D. A., Wright R. Bleeding oesophageal varices associated with anabolic steroid use in an athlete. Postgrad Med J. 1990 Oct;66(780):864–865. doi: 10.1136/pgmj.66.780.864. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES